• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8

CATEGORIES

  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

2
3
3
10

PUBLISHED

3
3
5
10

PRODUCT TYPE

8
2

Search "CNS Drug Discoveries: Multiple Sclerosis Chapter" returned 10 results.

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

July 2015
FROM
Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

July 2015
FROM

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 2

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an ebook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for...

October 2013

Multiple Sclerosis Treatments: World Market Outlook to 2011

Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although...

June 2007
FROM

Autoimmune Partnering Terms and Agreements

The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading...

March 2015
FROM

Autoimmune Disease Partnering Terms and Agreements

"The Autoimmune Disease Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by...

March 2015
FROM

Drug Discovery. Practices, Processes, and Perspectives

Sets forth the history, state of the science, and future directions of drug discovery Edited by Jie Jack Li and Nobel laureate E. J. Corey, two leading pioneers in drug discovery and medicinal chemistry,...

April 2013
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

July 2015
FROM

Stem Cell Markets

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions...

August 2013
FROM

Regenerative Medicine Markets

Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement As such, astounding new advancements in...

March 2013
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group